3PBIOVIAN

Logotipo 3PBIOVIAN def

Contact information

3P Biopharmaceuticals, SL
Dámaso Molero, Director General
Polígono Mocholí, C/ Mocholí nº 2
Noáin
Navarra
948346480
948346702
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • Cell cultures
      • Drug development
      • Cellular Therapy
      • Vaccines
      • Maintenance of cell cultures
  • C. Industrial Biotechnology
    • APIs and green chemistry
    • Enzymes
    • Fermentation or biocatalysis
    • Cell lines
    • Microorganism
  • D. Services
    • R&D services
      • CRO / CMO / SMO
  • Supplies and materials providers

3PBIOVIAN is a Contract Development and Manufacturing Organization (CDMO) that operates globally, providing comprehensive services to biotechnology and pharmaceutical companies.

Its service offering includes expression and production platforms for proteins based on microbial strains and mammalian cells, plasmid DNA, viral vectors for adenoviruses and adeno-associated viruses — AAVion™ — for gene therapy, as well as cell therapy products.

The company features state-of-the-art, technologically advanced facilities, including Fill and Finish services for recombinant proteins and viral vectors.

3PBIOVIAN operates two manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland, which efficiently meet the diverse needs of its clients — from preclinical and clinical supply to large-scale commercial manufacturing.
 

Products and services

3P Biopharmaceuticals is equipped to handle:

New Biological Entities (NBEs)

  • Recombinant proteins
  • Vaccines
  • Monoclonal antibodies

Biosimilars and Biobetters

Advanced Therapy products Manufacturing

  • Cell Therapy producs
  • Tissue Engineering products
  • Culture media
  • Biomaterials (scaffolds and membranes)
  • Viral Vectors (Adenovirus & AAVs)
  • Plasmid DNA
Areas of interest for future collaborations
  • Development and Manufacturing of New Biological entities
  • Development and Manufacturing of BiosimilarsCooperation in National and International grants
  • Development of Industrial processes
  • Development of new Technologies and Manufacturing platforms

Biotech Sanitaria

Research Platforms
Product / Service Type Development phase
Comparability studies services CMO, CRO Registration
GMP manufacturing services for Clinical Trials and Commercial CMO, CRO Registration
DS & DP Testing and release CMO, CRO Registration
GMP manufacturing microbial services (up to 1000L) CMO, CRO Registration
Cell therapy services CMO, CRO Registration
Technology transfer, Scale-up and non-GMP manufacturing services CMO, CRO Registration
GMP manufacturing mammalian services (up to 2000L) CMO, CRO Registration
NBE and Biosimilars: Analytical methods CMO, CRO Registration
Process development, optimization and formulation development CMO, CRO Registration
Mammalian cell line development CMO, CRO Registration
GMP Cell Bank Manufacturing CMO, CRO Registration
Strain development and RCB manufacturing CMO, CRO Registration
Stability studies services CMO, CRO Registration